INTEGRATED BIOPHARMA INC Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Integrated Biopharma Inc quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Integrated Biopharma Inc Return On Assets for the quarter ending March 31, 2024 was -0.44 %, a 108% decline year-over-year.
  • Integrated Biopharma Inc annual Return On Assets for 2023 was -0.13 %, a 101% decline from 2022.
  • Integrated Biopharma Inc annual Return On Assets for 2022 was 14.7 %, a 53.4% decline from 2021.
  • Integrated Biopharma Inc annual Return On Assets for 2021 was 31.6 %, a 60% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -0.13 -14.8 -101% Jul 1, 2022 Jun 30, 2023
2022 14.7 -16.9 -53.4% Jul 1, 2021 Jun 30, 2022
2021 31.6 +11.8 +60% Jul 1, 2020 Jun 30, 2021
2020 19.8 +11.7 +147% Jul 1, 2019 Jun 30, 2020
2019 8.01 +3.34 +71.6% Jul 1, 2018 Jun 30, 2019
2018 4.67 +5.64 Jul 1, 2017 Jun 30, 2018
2017 -0.97 -7.2 -116% Apr 1, 2017 Mar 31, 2018
2016 6.23 +0.44 +7.61% Apr 1, 2016 Mar 31, 2017
2015 5.78 +4.65 +410% Jul 1, 2014 Jun 30, 2015
2014 1.13 +0.41 +56.3% Jul 1, 2013 Jun 30, 2014
2013 0.73 +23.5 Jul 1, 2012 Jun 30, 2013
2012 -22.8 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.